Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Additional Routes of Drug Administration01:18

Additional Routes of Drug Administration

5.0K
Choosing the appropriate route of drug administration is significantly influenced by two key factors: the therapeutic objectives and the inherent properties of the drug being used.
Administering drugs via inhalation allows for the direct delivery of gaseous, volatile substances or droplets to different parts of the respiratory tract. One of the advantages of the inhalation route is the rapid absorption of drugs into the circulatory system, which is possible because of the large surface area of...
5.0K
Routes of Drug Administration: Enteral01:18

Routes of Drug Administration: Enteral

6.6K
Medications can be administered through the enteral route using liquids, capsules, or tablets.
Enteral administration involves drug administration via the mouth in two ways: orally or sublingually.
Unlike sublingually drugs, drugs that are taken orally pass through the gastrointestinal (GI) tract and get metabolized by the liver. Once metabolized, the drug is absorbed into the systemic circulation, reaching different body parts via the bloodstream. However, while passing through the stomach,...
6.6K
Routes of Drug Administration: Parenteral01:25

Routes of Drug Administration: Parenteral

3.0K
The administration of drugs via parenteral routes allows for direct drug introduction into the systemic circulation, resulting in high bioavailability because the medication bypasses the harsh conditions of the gastrointestinal tract and hepatic metabolism.
The intravenous route (IV) of drug administration can be further categorized into two types. The bolus injection administers the entire dose rapidly, while an intravenous infusion slowly delivers smaller doses steadily.
The IV route is often...
3.0K
Routes of Drug Administration: Overview01:22

Routes of Drug Administration: Overview

9.7K
Drug administration involves delivering drugs to the body through various routes, such as enteral, parenteral, and topical.
Enteral administration refers to drugs absorbed through the gastrointestinal tract. They can be swallowed (perorally), placed under the tongue (sublingually), or on the inner lining of the cheeks (buccally). Perorally administered drugs take time to be absorbed and have a slower onset of action. The rectal route is another form of enteral administration, which allows for...
9.7K
Two-Compartment Open Model: Extravascular Administration01:12

Two-Compartment Open Model: Extravascular Administration

687
The two-compartment model for extravascular administration represents a drug's absorption and distribution process. It features a central compartment, where the drug is first absorbed, and a peripheral compartment, which illustrates the drug's distribution throughout the body. The rate of change in drug concentration in the central compartment is calculated by three exponents: absorption, distribution, and elimination.
The absorption exponent (ka) indicates the speed at which the drug...
687
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

1.4K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Treatment patterns for patients with initial diagnosis of smoldering multiple myeloma in the United States: a SEER-Medicare analysis.

Haematologica·2026
Same author

Potential Benefits and Harms of Screening Strategies for Monoclonal Gammopathy of Undetermined Significance in the US: A Simulation Study.

Clinical lymphoma, myeloma & leukemia·2026
Same author

Real-World Utilization of Daratumumab in Front-Line Treatment of Newly Diagnosed Multiple Myeloma Across a Regional Academic-Community Network.

Cancers·2026
Same author

Real-world investigation of platelet apoptosis for mechanistic insights into severe immune thrombocytopenia and bleeding.

Research and practice in thrombosis and haemostasis·2026
Same author

Cumulative Antigen Suppression Reduces Clonal Plasma Cell Evolution in Gaucher Disease.

American journal of hematology·2026
Same author

Immunomodulatory Agent Adherence Trajectories and Survival Among Older Patients With Multiple Myeloma.

JCO oncology practice·2026

Related Experiment Video

Updated: Feb 10, 2026

Assessment of Ultrasonic Vocalizations During Drug Self-administration in Rats
09:25

Assessment of Ultrasonic Vocalizations During Drug Self-administration in Rats

Published on: July 22, 2010

18.0K

Hyperbilirubinemia following lenalidomide administration.

Veronica Azmy1, Natalia Neparidze2

  • 1Yale University School of Medicine New Haven CT 06510.

Clinical Case Reports
|May 11, 2018
PubMed
Summary

Lenalidomide therapy can unmask undiagnosed Gilbert's syndrome, causing asymptomatic hyperbilirubinemia. This condition typically resolves after discontinuing the medication.

Area of Science:

  • Pharmacology
  • Hepatology
  • Genetics

Background:

  • Lenalidomide is a medication used in treating multiple myeloma and other conditions.
Keywords:
Gilbert's syndromechemotherapyhyperbilirubinemialenalidomidemultiple myeloma

More Related Videos

Methods for Intravenous Self Administration in a Mouse Model
12:09

Methods for Intravenous Self Administration in a Mouse Model

Published on: December 8, 2012

55.1K
Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration
07:59

Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration

Published on: April 4, 2022

1.8K

Related Experiment Videos

Last Updated: Feb 10, 2026

Assessment of Ultrasonic Vocalizations During Drug Self-administration in Rats
09:25

Assessment of Ultrasonic Vocalizations During Drug Self-administration in Rats

Published on: July 22, 2010

18.0K
Methods for Intravenous Self Administration in a Mouse Model
12:09

Methods for Intravenous Self Administration in a Mouse Model

Published on: December 8, 2012

55.1K
Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration
07:59

Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration

Published on: April 4, 2022

1.8K
  • Hyperbilirubinemia, elevated bilirubin levels, can occur as a side effect of certain medications.
  • Gilbert's syndrome is a common, benign genetic condition causing mild hyperbilirubinemia.